- ADI-PEG 20 (oncology) general:
- ADI-PEG 20 (oncology) hepatocellular carcinoma:
- ADI-PEG 20 (oncology) melanoma:
- ADI-PEG 20 (oncology) mesothelioma:
- ADI-PEG 20 (oncology) ovarian cancer:
- ADI-PEG 20 (oncology) pancreatic cancer:
- ADI-PEG 20 (oncology) prostate cancer:
- ADI-PEG 20 (oncology) sarcoma:
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis
R.H. Kim, J.M. Coates, T.L. Bowles, G.P. McNerney, J. Sutcliffe, J.U. Jung, R. Gandour-Edwards, F.Y. Chuang, R.J. Bold, and H.J. KungCancer Research (2009), Vol. 69 pages 700-708
ADI, autophagy, and apoptosis: metabolic stress as a therapeutic option for prostate cancer
R.H. Kim, R.J. Bold, H.J. KungAutophagy (2009), Vol. 5 pages 567-568